PT  - JOURNAL ARTICLE
AU  - Ariel Pradipta
AU  - Miwa Sasai
AU  - Kou Motani
AU  - Ji Su Ma
AU  - Youngae Lee
AU  - Hidetaka Kosako
AU  - Masahiro Yamamoto
TI  - Cell-autonomous <em>Toxoplasma</em> killing program requires Irgm2 but not its microbe vacuolar localization
AID  - 10.26508/lsa.202000960
DP  - 2021 Jul 01
TA  - Life Science Alliance
PG  - e202000960
VI  - 4
IP  - 7
4099  - https://www.life-science-alliance.org/content/4/7/e202000960.short
4100  - https://www.life-science-alliance.org/content/4/7/e202000960.full
SO  - Life Sci. Alliance2021 Jul 01; 4
AB  - Interferon-inducible GTPases, such as immunity-related GTPases (IRGs) and guanylate-binding proteins (GBPs), are essential for cell-autonomous immunity against a wide variety of intracellular pathogens including Toxoplasma. IRGs comprise regulatory and effector subfamily proteins. Regulatory IRGs Irgm1 and Irgm3 play important roles in anti-Toxoplasma immunity by globally controlling effector IRGs and GBPs. There is a remaining regulatory IRG, called Irgm2, which highly accumulates on parasitophorous vacuole membranes (PVMs). Very little is known about the mechanism of the unique localization on Toxoplasma PVMs. Here, we show that Irgm2 is important to control parasite killing through recruitment of Gbp1 and Irgb6, which does not require Irgm2 localization at Toxoplasma PVMs. Ubiquitination of Irgm2 in the cytosol, but not at the PVM, is also important for parasite killing through recruitment of Gbp1 to the PVM. Conversely, PVM ubiquitination and p62/Sqstm1 loading at later time points post-Toxoplasma infection require Irgm2 localization at the PVM. Irgm2-deficient mice are highly susceptible to Toxoplasma infection. Taken together, these data indicate that Irgm2 selectively controls accumulation of anti-Toxoplasma effectors to the vacuole in a manner dependent or independent on Irgm2 localization at the Toxoplasma PVM, which mediates parasite killing.